Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Hoth Therapeutics, Inc. | CEO and President, Director | Common Stock | 58.1K | $38.9K | $0.67 | Aug 16, 2024 | Direct |
Hoth Therapeutics, Inc. | CEO and President, Director | Options | 325K | Aug 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HOTH | Hoth Therapeutics, Inc. | Aug 19, 2024 | 1 | $0 | 4 | Aug 21, 2024 | CEO and President, Director |
HOTH | Hoth Therapeutics, Inc. | Aug 16, 2024 | 1 | $16.8K | 4 | Aug 19, 2024 | CEO and President, Director |
HOTH | Hoth Therapeutics, Inc. | Jan 5, 2024 | 1 | $0 | 4 | Jan 8, 2024 | CEO and President, Director |
HOTH | Hoth Therapeutics, Inc. | Jul 17, 2023 | 1 | $0 | 4 | Jul 18, 2023 | CEO and President, Director |
HOTH | Hoth Therapeutics, Inc. | Sep 19, 2022 | 1 | $3.9K | 4 | Sep 20, 2022 | CEO and President, Director |
HOTH | Hoth Therapeutics, Inc. | Sep 16, 2022 | 1 | $4K | 4 | Sep 19, 2022 | CEO and President, Director |
HOTH | Hoth Therapeutics, Inc. | Mar 16, 2022 | 1 | $0 | 4 | Mar 18, 2022 | CEO and President, Director |